Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of renal cell carcinoma prognosis and treatment selection with carbonic anhydrase IX

Methods of renal cell carcinoma prognosis and treatment selection with carbonic anhydrase IX

US Patent 8936914 · Granted Jan 20, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Systems and methods for intramedullary preparations2021
Methods and compositions for treating cancer2020
Fusion molecule based on TAA variant2019
Kidney-specific tumor vaccine directed against kidney tumor antigen G-2502018
Fusion molecule based on novel TAA variant2018
Fusion molecule based on novel TAA variant2016
Kidney-specific tumor vaccine directed against kidney tumor antigen G-2502016
Fusion molecule based on novel TAA variant2016
CA9 gene single nucleotide polymorphisms predict prognosis and treatment respons2014
Kidney specific tumor vaccine directed against kidney tumor antigen G-2502014
Fusion molecule based on novel TAA variant2013
Kidney-specific tumor vaccine directed against kidney tumor antigen G-2502009